Regeneron Reports First Quarter 2021 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Regeneron (REGN) Tops Q1 EPS by 89c, Revenues Miss
May 6, 2021 6:35 AM EDTRegeneron (NASDAQ: REGN) reported Q1 EPS of $9.89, $0.89 better than the analyst estimate of $9.00. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.55 billion.
First quarter 2021 revenues increased 38% to $2.53 billion versus first quarter 2020; revenues excluding REGEN-COVTM(1) increased 20%First quarter 2021 EYLEA® U.S. net sales increased 15% to $1.35 billion versus first quarter 2020First quarter 2021 Dupixent® global net... More